{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:44:01Z","timestamp":1794433441256,"version":"4.9.1"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pneurobio.2019.101722","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T11:33:23Z","timestamp":1573558403000},"page":"101722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications"],"prefix":"10.1016","volume":"184","author":[{"given":"Joseph H.","family":"Neale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2019.101722_bib0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1744-8069-6-60","article-title":"Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity\/transmission in the amygdala in a mouse inflammatory pain model","volume":"6","author":"Adedoyin","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0304-3940(86)90610-5","article-title":"Localization of N-acetylaspartylglutamate-like immunoreactivity in selected areas of the rat brain","volume":"72","author":"Anderson","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0015","doi-asserted-by":"crossref","DOI":"10.1080\/23723556.2019.1627273","article-title":"Dual role of N-acetyl-aspartylglutamate metabolism in cancer monitor and therapy","author":"Asaka","year":"2019","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-4159.2005.03361.x","article-title":"Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury","volume":"95","author":"Bacich","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s00259-017-3922-y","article-title":"Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives","volume":"45","author":"Backhaus","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0030","first-page":"145","article-title":"NAAG peptidase as a therapeutic target: potential for regulating the link between glucose metabolism and cognition","volume":"19","author":"Baslow","year":"2014","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuroscience.2011.12.044","article-title":"Opposite regulation of metabotropic glutamate receptor 3 and metabotropic glutamate receptor 5 by inflammatory stimuli in cultured microglia and astrocytes","volume":"205","author":"Berger","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1471-4159.2006.04253.x","article-title":"Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus","volume":"100","author":"Bergeron","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0045","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2174\/0929867321666140916120118","article-title":"The glutamate hypothesis in ALS: pathophysiology and drug development","volume":"21","author":"Blasco","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1471-4159.2004.02361.x","article-title":"The cloning and characterization of a second brain enzyme with NAAG peptidase activity","volume":"89","author":"Bzdega","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0055","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1046\/j.1471-4159.1997.69062270.x","article-title":"Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library","volume":"69","author":"Bzdega","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0060","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/npp.2013.106","article-title":"The mGluR2\/3 agonist LY379268 induced anti-reinstatement effects in rats exhibiting addiction-like behavior","volume":"38","author":"Cannella","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0065","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1471-4159.1987.tb01030.x","article-title":"Immunohistochemistry and biosynthesis of N-acetylaspartylglutamate in spinal sensory ganglia","volume":"49","author":"Cangro","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12868-016-0251-1","article-title":"Glutamate carboxypeptidase II gene knockout attenuates oxidative stress and cortical apoptosis after traumatic brain injury","volume":"17","author":"Cao","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0075","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2967\/jnumed.112.104661","article-title":"Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer","volume":"53","author":"Carducci","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.npep.2003.08.001","article-title":"Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat","volume":"37","author":"Carpenter","year":"2003","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002130050072","article-title":"Attenuation of specific PCP-evoked behaviors by the potent mGlu2\/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine","volume":"148","author":"Cartmell","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0143-4179(93)90015-3","article-title":"N-acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia","volume":"24","author":"Cassidy","year":"1993","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0095","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/gps.4686","article-title":"Associations between pro-inflammatory cytokines, learning, and memory in late-life depression and healthy aging","volume":"33","author":"Charlton","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.apha.2015.11.001","article-title":"Modulation of chronic pain by metabotropic glutamate receptors","volume":"75","author":"Chiechio","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0110","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2967\/jnumed.112.104661","article-title":"Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer","volume":"53","author":"Cho","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0115","doi-asserted-by":"crossref","first-page":"38220","DOI":"10.1074\/jbc.M111.287318","article-title":"Molecular identification of \u03b2-citrylglutamate hydrolase as glutamate carboxypeptidase 3","volume":"286","author":"Collard","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1471-4159.1965.tb06771.x","article-title":"Distribution of N-acetyl-aspartic and N-acetyl-aspartyl-glutamic acids in nervous tissue","volume":"12","author":"Curatolo","year":"1965","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2017.01.036","article-title":"Local enema treatment to inhibit FOLH1\/GCPII as a novel therapy for inflammatory bowel disease","volume":"263","author":"Date","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0130","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0135","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.brainres.2012.06.021","article-title":"NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxia","volume":"1469","author":"Feng","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainres.2011.04.022","article-title":"Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI","volume":"1395","author":"Feng","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0145","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.neuropharm.2009.03.002","article-title":"Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR","volume":"56","author":"Fricker","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1471-4159.1994.62010275.x","article-title":"The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system","volume":"62","author":"Fuhrman","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0155","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1523\/JNEUROSCI.2042-05.2005","article-title":"Activity-dependent differential transmitter release in mouse adrenal chromaffin cells","volume":"25","author":"Fulop","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00023210-200115010-00004","article-title":"Glutamate receptors and nociception: implications for the drug treatment of pain","volume":"15","author":"Fundytus","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/jnc.13123","article-title":"Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury","volume":"134","author":"Gao","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0170","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1471-4159.2004.02578.x","article-title":"Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia","volume":"90","author":"Gehl","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0175","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1073\/pnas.1530168100","article-title":"Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models","volume":"100","author":"Ghadge","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0180","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/appi.ajp.2009.08091445","article-title":"Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?","volume":"166","author":"Ghose","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2013.03.043","article-title":"NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia","volume":"1515","author":"Gurkoff","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0190","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/jco.2015.33.15_suppl.2512","article-title":"Safety and tolerability of increasing doses of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase, in solid tumors","volume":"33","author":"Harding","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0195","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00213-017-4568-y","article-title":"Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)","volume":"234","author":"Hicks","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0200","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JAD-181251","article-title":"The NAAG\u2019ing concerns of modeling human Alzheimer\u2019s disease in mice","volume":"68","author":"Hollinger","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2990.2012.01307.x","article-title":"Review: systemic inflammation and Alzheimer's disease","volume":"39","author":"Holmes","year":"2013","journal-title":"Neuropathol Appl Neurobiol ."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J. PsychopharmacoI."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(98)00918-2","article-title":"Induction of long-lasting depression by (+)-alpha-methyl-4-carboxyphenylglycine and other group II mGlu receptor ligands in the dentate gyrus of the hippocampus in vitro","volume":"366","author":"Huang","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2012.11.027","article-title":"NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test","volume":"701","author":"Janczura","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0225","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/schbul\/sbs100","article-title":"Twenty-five years of glutamate in schizophrenia: are we there yet?","volume":"38","author":"Javitt","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0230","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1021\/jm950801q","article-title":"Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase","volume":"39","author":"Jackson","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0235","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","article-title":"Neuroimmunology of traumatic brain injury: time for a paradigm shift","volume":"95","author":"Jassam","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.20171052","article-title":"Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors","volume":"215","author":"Kaittanis","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0245","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.nbd.2015.08.017","article-title":"Differential effects of N-acetyl-aspartyl-glutamate on synaptic and extrasynaptic NMDA receptors are subunit- and pH-dependent in the CA1 region of the mouse hippocampus","volume":"82","author":"Khacho","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0250","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbb.2019.01.007","article-title":"Neuroinflammation in addiction: a review of neuroimaging studies and potential immunotherapies","volume":"179","author":"Kohno","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0260","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2741\/4742","article-title":"GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond","volume":"24","author":"Kovalinka","year":"2019","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0265","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm000406m","article-title":"Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)","volume":"44","author":"Kozikowski","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0270","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbr.2014.03.008","article-title":"mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests","volume":"266","author":"Lainiola","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(99)00814-9","article-title":"Distribution of the group II metabotropic glutamate receptors (mGluR2\/3) in the enteric nervous system of the rat","volume":"276","author":"Larzabal","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0280","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/jn.2001.85.3.1097","article-title":"beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor","volume":"85","author":"Lea","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0285","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1159\/000356611","article-title":"Transplantation of N -acetyl aspartyl-glutamate synthetase-activated neural stem cells after experimental traumatic brain injury significantly improves neurological recovery","volume":"32","author":"Li","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0290","doi-asserted-by":"crossref","first-page":"16693","DOI":"10.1074\/jbc.M111.230136","article-title":"N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate","volume":"286","author":"Lodder-Gadaczek","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0295","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neuropharm.2003.10.007","article-title":"NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons","volume":"46","author":"Losi","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0300","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1073\/pnas.95.6.3215","article-title":"Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II","volume":"95","author":"Luthi-Carter","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0305","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/1078-0432.CCR-07-1517","article-title":"N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer","volume":"14","author":"Mease","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0310","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/oxfordjournals.jbchem.a022531","article-title":"Structural organization of the mouse metabotropic glutamate receptor subtype 3 gene and its regulation by growth factors in cultured cortical astrocytes","volume":"126","author":"Minoshima","year":"1999","journal-title":"J. Biochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0315","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1471-4159.1966.tb10297.x","article-title":"Identification of N-acetylalpha-aspartylglutamic acid in the bovine brain","volume":"13","author":"Miyamoto","year":"1966","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0320","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/41.4.8450195","article-title":"Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain","volume":"41","author":"Moffett","year":"1993","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0325","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2010.01.030","article-title":"Group II metabotropic glutamate receptors (mGlu2\/3) in drug addiction","volume":"639","author":"Moussawi","year":"2010","journal-title":"Eur. J. PharmacoI."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/neu.2006.23.117","article-title":"Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury","volume":"23","author":"Movsesyan","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0335","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.neuropharm.2006.07.018","article-title":"Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration","volume":"51","author":"Nagel","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0340","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.2000.0750443.x","article-title":"N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system","volume":"75","author":"Neale","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nlm.2019.01.006","article-title":"A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognition","volume":"158","author":"Neale","year":"2019","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0350","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-4159.2011.07338.x","article-title":"Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family","volume":"118","author":"Neale","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0355","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.celrep.2019.03.036","article-title":"Uncovering the role of N-Acetyl-Aspartyl-Glutamate as a glutamate reservoir in Cancer","volume":"27","author":"Nguyen","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0360","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917697008","article-title":"A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA","volume":"13","author":"Nonaka","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0365","article-title":"Dendritic localization and exocytosis of NAAG in the rat Hippocampus","author":"Nordengen","year":"2019","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0370","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.117.203877","article-title":"A perspective on the evolving story of PSMA biology, PSMA-based imaging, and endoradiotherapeutic strategies","volume":"59","author":"O\u2019Keefe","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0375","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-4781(98)00200-0","article-title":"Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene","volume":"1143","author":"O\u2019Keefe","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2741\/4193","article-title":"Antibody-drug conjugates targeting prostate-specific membrane antigen","volume":"19","author":"Olson","year":"2014","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0385","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1038\/tp.2012.68","article-title":"NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia","volume":"2","author":"Olszewski","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0390","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s11064-017-2181-4","article-title":"NAAG peptidase inhibitors act via mGluR3: animal models of memory, alzheimer\u2019s, and ethanol intoxication","volume":"42","author":"Olszewski","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0395","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-4159.2004.02358.x","article-title":"NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR","volume":"89","author":"Olszewski","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0400","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.schres.2012.01.007","article-title":"mGluR3 and not mGluR2 receptors mediate the efficacy of NAAG peptidase inhibitor in validated model of schizophrenia","volume":"136","author":"Olszewski","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0405","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biopsych.2007.04.016","article-title":"Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors","volume":"63","author":"Olszewski","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0410","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2009.10.062","article-title":"Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats","volume":"627","author":"Peng","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0415","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fnmol.2018.00464","article-title":"Emerging trends in pain modulation by metabotropic glutamate receptors","volume":"11","author":"Pereira","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0420","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.pharep.2017.04.016","article-title":"Neuroadaptive changes in metabotropic glutamate mGlu2\/3R expression during different phases of cocaine addiction in rats","volume":"69","author":"Pomierny-Chamiolo","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0425","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/cercor\/bhi022","article-title":"The metabotropic glutamate receptor mGluR3 is critically required for hippocampal long-term depression and modulates long-term potentiation in the dentate gyrus of freely moving rats","volume":"15","author":"P\u00f6schel","year":"2005","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102936","article-title":"Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats","volume":"9","author":"Potter","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0435","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00213-011-2200-0","article-title":"Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia","volume":"216","author":"Profaci","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0440","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1073\/pnas.1209934109","article-title":"Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis","volume":"109","author":"Rahn","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131861","article-title":"Selective CNS uptake of the GCP-II inhibitor 2-PMP following intranasal administration","volume":"10","author":"Rais","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0450","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88634","article-title":"FOLH1\/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities","volume":"1","author":"Rais","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0455","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.urolonc.2013.09.003","article-title":"The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research","volume":"32","author":"Ristau","year":"2014","journal-title":"Urol OncoI."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0460","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/0269881116667668","article-title":"Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine","volume":"30","author":"Reynolds","year":"2016","journal-title":"J Psychopharmacol ."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0465","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0006-8993(84)90727-3","article-title":"A study of possible excitatory effects of N-acetylaspartylglutamate in different in vivo and in vitro brain preparations","volume":"299","author":"Riveros","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0470","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2012.05.030","article-title":"Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2\/3 ligands and activated by N-acetylaspartylglutamate (NAAG)","volume":"66","author":"Romei","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0475","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-007-0758-3","article-title":"In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2\/3 receptor agonist LY404039 in animal models of psychiatric disorders","volume":"193","author":"Rorick-Kehn","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0480","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF03022832","article-title":"Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain","volume":"53","author":"Saito","year":"2006","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0485","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.172","article-title":"Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk","volume":"7","author":"Saini","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0490","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1152\/jn.00465.2003","article-title":"GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism","volume":"91","author":"Sanabria","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0495","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2967\/jnumed.118.212720","article-title":"Synthesis and preclinical characterization of the PSMA-Targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate Cancer","volume":"60","author":"Schottelius","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0500","doi-asserted-by":"crossref","first-page":"31006","DOI":"10.1074\/jbc.272.49.31006","article-title":"Cloning and characterization of a novel peptidase from rat and human ileum","volume":"272","author":"Shneider","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0505","doi-asserted-by":"crossref","first-page":"21297","DOI":"10.1016\/S0021-9258(17)45359-2","article-title":"Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization","volume":"265","author":"Slusher","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0510","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/70971","article-title":"Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury","volume":"5","author":"Slusher","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0515","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00213-004-2126-x","article-title":"Effects of the mGluR2\/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys","volume":"179","author":"Spinelli","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0520","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2010.11.048","article-title":"Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits inmice","volume":"1371","author":"Takatsu","year":"2011","journal-title":"Brain Res ."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0525","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(87)90259-9","article-title":"N-acetylaspartylglutamate immunoreactivity in neurons of the cat\u2019s visual system","volume":"420","author":"Tieman","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0530","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(00)00519-7","article-title":"Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons","volume":"402","author":"Tortella","year":"2000","journal-title":"Eur. J. PharmacoI."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0535","doi-asserted-by":"crossref","first-page":"11321","DOI":"10.1074\/jbc.M114.628149","article-title":"Structural and biochemical characterization of a novel aminopeptidase from human intestine","volume":"290","author":"Tykvart","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0540","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.pmch.2018.12.001","article-title":"Amyotrophic lateral sclerosis","volume":"58","author":"Valko","year":"2019","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0545","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1124\/jpet.113.205039","article-title":"Pharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism","volume":"346","author":"Vornov","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0550","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/acs.bioconjchem.8b00292","article-title":"Radioligand therapy of prostate Cancer with a long-lasting prostate-specific membrane antigen targeting agent 90Y-DOTA-EB-MCG","volume":"18","author":"Wang","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0555","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1021\/acs.bioconjchem.8b00556","article-title":"Single low-dose injection of evans blue modified PSMA-617 radioligand therapy eliminates prostate-specific membrane antigen positive tumors","volume":"29","author":"Wang","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0560","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0006-8993(88)90243-0","article-title":"Ultrastructural localization of N-acetylaspartylglutamate in synaptic vesicles of retinal neurons","volume":"456","author":"Williamson","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0565","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0028-3908(02)00124-7","article-title":"NAALADase (GCP II) inhibition prevents cocaine-kindled seizures","volume":"43","author":"Witkin","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0570","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.112.197665","article-title":"The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy","volume":"343","author":"Wozniak","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0575","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6","article-title":"N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes","volume":"24","author":"Wroblewska","year":"1998","journal-title":"Glia"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0580","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1471-4159.2005.03569.x","article-title":"Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes","volume":"96","author":"Wroblewska","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0585","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2009.06.016","article-title":"N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats","volume":"58","author":"Xi","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0590","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1744-8069-8-67","article-title":"NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammation","volume":"8","author":"Yamada","year":"2012","journal-title":"Mol. Pain"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0595","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1460-9568.2004.03504.x","article-title":"Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0600","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1744-8069-4-31","article-title":"Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain","volume":"4","author":"Yamamoto","year":"2008","journal-title":"Mol. Pain"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0605","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0006-8993(01)02650-6","article-title":"Spinal N-acetyl-alpha-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat","volume":"909","author":"Yamamoto","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0610","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1460-9568.2006.05272.x","article-title":"Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats","volume":"25","author":"Yamamoto","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0615","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jns.2006.05.052","article-title":"The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy","volume":"247","author":"Zhang","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0620","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-510X(01)00670-0","article-title":"GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB\/Wor rats","volume":"194","author":"Zhang","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0625","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.035","article-title":"Suppression of glutamate carboxypeptidase II ameliorates neuronal apoptosis from ischemic brain injury","volume":"25","author":"Zhang","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0630","first-page":"340","article-title":"NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance","volume":"13","author":"Zhao","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0635","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1089\/neu.2005.22.266","article-title":"NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats","volume":"22","author":"Zhong","year":"2005","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.pneurobio.2019.101722_bib0640","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1471-4159.2006.03786.x","article-title":"NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat","volume":"97","author":"Zhong","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0645","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nrd1903","article-title":"NAAG peptidase inhibitors and their potential for diagnosis and therapy","volume":"4","author":"Zhou","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0650","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12264-017-0140-3","article-title":"N-acetylaspartylglutamate inhibits heroin self-administration and heroin-seeking behaviors induced by cue or priming in rats","volume":"33","author":"Zhu","year":"2017","journal-title":"Neurosci. BulI."},{"key":"10.1016\/j.pneurobio.2019.101722_bib0655","doi-asserted-by":"crossref","first-page":"21773","DOI":"10.1074\/jbc.M112.363226","article-title":"Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia","volume":"287","author":"Zuo","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008219303405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008219303405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:03:55Z","timestamp":1759550635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008219303405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":131,"alternative-id":["S0301008219303405"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101722","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101722"}}